Logo for LaunchBio Program: Investor ConnectLogo for LaunchBio Program: Investor Connect

Bridging the Gap Between Innovation and Capital


OrbiMed Advisors

Focus on therapeutic companies


Calling all therapeutics companies!

OrbiMed is a global, multi-stage healthcare investment firm. Its private investment strategy is broad and flexible, investing from start-ups through growth equity. OrbiMed is typically a lead investor, helping to build our portfolio companies into market leaders.



LaunchBio and Silicon Valley Bank, a division of First Citizens Bank, are pleased to announce their next Investor Connect virtual event with OrbiMed.

Applications will be selected based on meeting the following criteria:

Not restricted.

Company type:
Therapeutics companies; late preclinical or clinical stage.

Areas of Interest:

  • Therapeutics
    • Human
  • Therapeutic modalities of interest include, (but not limited to):
    • Small Molecules
    • Biologics
    • Genetic Medicines
  • Research areas of interest include, (but not limited to):
    • Oncology
    • Immunology
    • Cardiovascular
    • Renal

Companies seeking Series A, Series B or later funding.

Qualifying start-ups can apply here today.

Applications are accepted on a rolling basis. Learn more about LaunchBio’s Investor Connect series, in partnership with Silicon Valley Bank, a division of First Citizens Bank.